Retraction: CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelialmesenchymal transition in hepatocellular carcinoma.
APA
Zheng X, Song T, et al. (2026). Retraction: CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelialmesenchymal transition in hepatocellular carcinoma.. Oncotarget, 17(1), 192. https://doi.org/10.18632/oncotarget.28873
MLA
Zheng X, et al.. "Retraction: CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelialmesenchymal transition in hepatocellular carcinoma.." Oncotarget, vol. 17, no. 1, 2026, pp. 192.
PMID
42030155
같은 제1저자의 인용 많은 논문 (5)
- ASO Visual Abstract: Short- and Long-term Patient Outcomes in Hospitals Primarily Serving Colorectal Cancer Patients from High-Poverty Areas-An Observational Cohort Study.
- PMs-Ti-based plasma extracellular vesicles glycoproteomics and its application in lung cancer.
- Short-and Long-term Patient Outcomes in Hospitals Primarily Serving Patients with Colorectal Cancer from High-Poverty Areas-An Observational Cohort Study.
- E2F1-driven cholesterol synthesis via the SND1/ACLY axis potentiates malignant progression in prostate cancer.
- Icaritin eliminates tumor-associated macrophages via STX16-dependent extracellular vesicle delivery of autophagosomes from hepatocellular carcinoma cells.